Apyx Medical Corporation

Historical 13F Holders

Symbol
APYX
CUSIP
03837C106
All holders as of
Q3 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 03837C106 since 12/18/2024, largest first.

Filer % of Class Filed
Nantahala Capital Management, LLC 13G/A
10.0% 2/13/2026
Event 12/31/2025
Royce & Associates LP 13G/A 7.8% 7/21/2026
Event 6/30/2026
Philotimo Fund, LP 13G
5.4% 10/28/2026
Event 10/21/2026

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 69 21.0 M $51.5M
2026 Q2 69 21.4 M $95.9M
2026 Q1 68 20.8 M $76.8M
2025 Q4 60 19.1 M $66.9M
2025 Q3 50 15.7 M $33.7M
2025 Q2 43 15.8 M $35.6M
2025 Q1 46 15.8 M $21.6M
2024 Q4 47 15.9 M $25.2M
2024 Q3 48 12.8 M $15.9M
2024 Q2 50 13.1 M $17.5M
2024 Q1 53 13.3 M $18.1M
2023 Q4 63 17.5 M $45.7M
2023 Q3 63 18.3 M $58.7M
2023 Q2 57 18.8 M $94.4M
2023 Q1 56 20.1 M $58.2M
2022 Q4 52 18.2 M $42.6M
2022 Q3 55 20.9 M $94.0M
2022 Q2 64 21.0 M $123M
2022 Q1 72 19.6 M $128M
2021 Q4 76 19.1 M $245M
2021 Q3 75 18.9 M $261M
2021 Q2 74 19.1 M $197M
2021 Q1 69 19.0 M $183M
2020 Q4 65 18.6 M $134M
2020 Q3 62 17.8 M $83.9M
2020 Q2 64 18.1 M $101M
2020 Q1 68 18.1 M $65.0M
2019 Q4 70 18.3 M $154M
2019 Q3 70 17.8 M $120M
2019 Q2 67 17.4 M $117M
2019 Q1 78 15.3 M $96.7M
2018 Q4 2 925 k $5.99M